<b>MODY is prevalent in later-onset diabetes, has potential for targeted therapy but is challenging to identify</b>

<b>MODY is prevalent in later-onset diabetes, has potential for targeted therapy but is challenging to identify</b>

<p dir="ltr">Maturity Onset Diabetes of the Young (MODY) can present after the age of 40 years, but its prevalence, clinical characteristics, and the utility of simple clinical features for selecting cases in this age group remain poorly defined. We analysed whole-exome and clinical...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autor: Luke N Sharp (22551717) (author)
Daljnji autori: Uyenlinh L Mirshahi (22551718) (author), Kevin Colclough (422231) (author), Timothy S Hall (22551719) (author), Jeremy S Haley (22551721) (author), Stuart J Cannon (22551727) (author), Thomas W Laver (22551731) (author), Michael N Weedon (21698) (author), Andrew T Hattersley (21706) (author), David J Carey (22551733) (author), Kashyap A Patel (22551735) (author)
Izdano: 2025
Teme:
Other biological sciences not elsewhere classified
Monogenic Diabetes
Maturity-Onset Diabetes of the Young (MODY)
Genetics & Genomics
Genetic Screening
Late Onset
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Slični predmeti